Efficacy and Safety of Lobeglitazone Versus Sitagliptin

NCT02480465 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Lobelitazone 0.5mg
DRUG: Sitagliptin 100mg

Sponsor

Chong Kun Dang Pharmaceutical